MedPath

Role of probiotics intake on the disease course of arthritis in children.

Phase 3
Conditions
Health Condition 1: M08- Juvenile arthritis
Registration Number
CTRI/2023/12/060403
Lead Sponsor
Indian Rheumatology Association
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Children with polyarthritis below 16 years will be included in the study. The diagnosis of polyarthritis will be established by criteria laid down by International League Association for Rheumatology (ILAR)

Exclusion Criteria

Children with diarrhea, exposure to antibiotics, and history of regular curd consumption in the previous 6 weeks will be exempted from participating in the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the effect of regular probiotic intake on the disease activity in juvenile idiopathic arthritis. <br/ ><br>Timepoint: The disease activity will be assessed by using Juvenile Disease Activity Score 10 (JADAS10) at 6 weeks 10 weeks 16 weeks, and end of the study.
Secondary Outcome Measures
NameTimeMethod
To evaluate the impact of regular probiotic intake on the gut microbiota <br/ ><br>in children with juvenile idiopathic arthritis.Timepoint: Gut microbiota of 15 cases of juvenile idiopathic arthritis & 15 controls will be assessed at the beginning & end of the study (1st week & at 20 weeks) <br/ ><br>by metagenome sequencing of stool samples.
© Copyright 2025. All Rights Reserved by MedPath